20041 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Pulmonary tract; Aromatherapy
AEROSOL GENERATOR
#302Treatment of airway disorders and cough
#303Hypothermal inhalation gas composition
#304THERMALLY NEUTRAL INHALATION GAS COMPOSITION
#305Vaporizer for vaporizing an active ingredient
#306Heating unit for use in a drug delivery device
#307THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND A STEROID FOR THE TREATMENT OF EVOLVING BPD
#308Methods of increasing lacrimal proteins
#309GM-CSF for treating refractory non-tuberculous mycobacteria infections
#310HYDROGEN-CONTAINING COMPOSITION
#311Osteoadsorptive fluorogenic substrate of cathepsin k for imaging osteoclast activity and migration
#312Inhalation of Nitric Oxide for Treating Respiratory Diseases
#313TREATMENT OF TYPE I AND TYPE II DIABETES
#314Automated production of viral vectors
#315Suppression of allergic lung inflammation and hyperreactivity
#316Method for treating inflammation or cancer using extracellular vesicles derived from
#317Method of identifying and treating premature infants at risk for BPD
#318Smokeless THC and Administration Method Thereof
#319Methods of treating neuropsychiatric disorders
#320AMORPHOUS NANOSTRUCTURED PHARMACEUTICAL MATERIALS
#321Electronic cigarette
#322Personal Care Composition With Increased Vapor Release
#323Smoking device
#324Smoking device
#325Surfactant Lipids, Compositions Thereof, and Uses Thereof
#326HISTONE DEACETYLASE INHIBITORS
#327VAPORIZABLE COMPOSITIONS COMPRISING CANNABINOL
#328COMPOSITIONS AND METHODS FOR IMPROVING COGNITION
#329Method of Treating Respiratory Tract Infection
#330GAS MIXTURES CONTAINING LOW CONCENTRATIONS OF XENON AND ARGON PROVIDE NEUROPROTECTION WITHOUT INHIBITING THE CATALYTIC ACTIVITY OF THROMBOLYTIC AGENTS
#331Modulation of the notch signaling pathway for treatment of respiratory disorders
#332Inhibition of pulmonary fibrosis with nutlin-3a and peptides
#333Methods for preventing and treating pneumocystis infections
#334System And Method Of Administering A Pharmaceutical Gas To A Patient
#335Use of inhibitors of Bruton's tyrosine kinase (Btk)
#336Crystalline spirocyclic compound, a dosage form containing, a method for using in treatment of disease, and a method for recrystallizing
#337Methods of treating basal cell carcinoma and glioblastoma
#338Method for Delivery of Medicaments via Vaporized Emu Oil Carrier
#339SUPERIOR CONTROL OF BLOOD GLUCOSE IN DIABETES TREATMENT
#340IMPLANTABLE DRUG DELIVERY COMPOSITIONS AND METHODS OF USE THEREOF
#341Methods and pharmaceutical compositions for the treatment of diseases associated with reduced CFTR function
#342Method of identifying a biologically-active composition from a biofilm
#343BIOAVAILABLE AEROSOLIZED SUPPLEMENT FORMULATIONS AND METHODS THEREOF
#344Hydrogen-containing composition for ameliorating depressive symptom
#345Ultrapure tetrahydrocannabinol-11-oic acids
#346Methods for integrative diagnosis and treatment and a kit for their implementation
#347Gene therapy for tuberous sclerosis
#348COMPOSITION COMPRISING HYDROGEN GAS FOR SUPPRESSION OR PREVENTION OF CANCER METASTASIS
#349METHOD OF TREATING OVARIAN CANCER USING ZETA-STAT
#350FORMULATIONS OF POLYINOSINIC ACID AND POLYCYTIDYLIC ACID FOR THE PREVENTION OF UPPER RESPIRATORY TRACT INFECTIONS
#351NRF2 activators
#352ANTIMICROBIAL COMPOSITIONS AND METHODS
#353Ion-exchange membrane electrolysis device
#354Medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity
#355Isolation of human lung progenitors derived from pluripotent stem cells
#356COMPOSITION FOR IMPROVEMENT OR PREVENTION OF PARKINSONIAN SYNDROME
#357COMPOSITION AND METHOD FOR IMPROVING QOL WITH MOLECULAR HYDROGEN IN CANCER- HAVING SUBJECT
#358LIQUID CANNABINOID COMPOSITION
#359IL-1 Binding Proteins
#360Composition for treatment or prevention of age-related macular degeneration comprising molecular hydrogen
#361Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor
#362Use of Antineoplastic Agents to Stimulate the Immune System for Treatment of Cancer
#363NOVEL MEANS TO DECREASE THE NEGATIVE EFFECTS OF SMOKING
#364Use of inhibitors of bruton's tyrosine kinase (BTK)
#365Process for the preparation of a PDE4 inhibitor
#366LIQUID FORMULATION COMPRISING NICOTINE FOR AEROSOL ADMINISTRATION
#367Methods for treating inflammatory conditions of the lungs
#368Drug Condensation Aerosols And Kits
#369Method and compositions for solubilizing non-polar constituents
#370Anti-fibrotic pyridinones
#371CANNABIS-BASED THERAPEUTIC PRODUCT FOR TREATMENT OF CHRONIC PAIN
#372Substituted benzodiazoliums as ENaC inhibitors
#373Use of ultrarapid acting insulin
#374Antiviral compositions for the treatment of infections linked to coronaviruses
#375Amino-pyrimidine skeletal muscle modulators
#376Dendritic-cell-targeted peptide, fusion peptide utilizing said peptide, and vaccine utilizing said fusion peptide
#377Systems and methods for a cooled nitric oxide generator
#378METHOD AND COMPOSITIONS FOR SOLUBILIZING NON-POLAR CONSTITUENTS
#379Flow regulating inhaler device
#380Radiation damage protective agent
#381CHIMERIC COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF
#382FOAM FOR PULMONARY DRUG DELIVERY
#383Regimen mattress
#384TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS
#385Compositions comprising antisense-encoded erythropoietin receptor and use thereof
#386Preparation of a solution of cannabinoids for personal vaping
#387Vaporizer
#388Hemostatic compositions and methods of making thereof
#389Liquid vape base and extraction process
#390Articles formed of pulp base materials with modulated scent release
#391Spherical microparticles with polyester walls
#392CANNABIS-BASED THERAPEUTIC PRODUCT FOR TREATMENT OF CHRONIC PAIN
#393ACTH PROPHYLACTIC TREATMENT OF RENAL DISORDERS
#394Nicotine salt with meta-salicylic acid and applications therein
#395Smoking device
#396Combinations comprising dibromopropamidine or diminazene and a tetracycline anti-bacterial agent
#397Phyto material tablet, method and apparatus
#398Particles with RNA cleaving nucleobase polymers and uses for managing inflammatory disorders
#399No-rinse chemical foam comprising ivermectin
#400Dosage form for vaporization and smoking
#401Pure heptasulfated disaccharides having improved oral bioavailability
#402Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children
#403Pheromone compositions for stimulating early onset of estrus and reducing labor needs in breeding peri-pubertal suids and methods of use
#404Nanovesicles derived from genus bacteria and use thereof
#405CANNABIS-BASED THERAPEUTIC PRODUCT FOR TREATMENT OF CHRONIC PAIN
#406METHODS AND COMPOSITIONS FOR TREATING LUNG DISEASE OF PREMATURITY
#407Inhalers and Related Methods
#408Compositions and methods for activating antigen presenting cells with chimeric poliovirus
#409Water-based vaporizable liquids, methods and systems for vaporizing same
#410METHOD FOR INCREASING THE BIOAVAILABILITY OF INHALED COMPOUNDS
#411THERAPEUTIC AGENT FOR DISEASE ACCOMPANIED BY EPILEPTIC WAVES
#412Drug-containing fat emulsion and nethod for producing same
#413WATER-BASED VAPORIZABLE LIQUIDS, METHODS AND SYSTEMS FOR VAPORIZING SAME
#414Compositions and methods useful for prophylaxis of organophosphates
#415Method and system for protecting honey bees from fipronil pesticides
#416Marker for Cancer Prognosis and Methods Related Thereto
#417COMPOSITION FOR REDUCING ANXIETY IN A COMPANION ANIMAL
#418Burn Pill Pharmaceutical Smoking Cylinder
#419NOBLE GAS MODULATION OF IL-12
#420Use of antistatic materials in the airway for thermal aerosol condensation process
#421Chimeric VSV virus compositions and methods of use thereof for treatment of cancer
#422N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress
#423COMPOSITIONS, SYSTEMS, METHODS, AND ARTICLES FOR RETRO-NASAL DELIVERY
#424WATER-BASED VAPORIZABLE LIQUIDS, METHODS AND SYSTEMS FOR VAPORIZING SAME
#425No-rinse chemical foam containing brimonidine, and use thereof in the treatment of rosacea
#426Chemically modified small molecules
#427Hot Oil Tank
#428Inhalable compositions comprising caffeine, methods of use and an apparatus for using the same
#429Conjugate with target-finding ligand and use thereof
#430Ultrapure tetrahydrocannabinol-11-oic acids
#431THERMALLY NEUTRAL INHALATION GAS COMPOSITION
#432METHODS OF TREATING DISEASES RELATED TO NET FORMATION WITH PARENTERAL ADMINISTRATION OF POLYSIALYLATED DNASE I
#433COMPOSITIONS AND METHODS FOR TREATMENT OF SHORT TELOMERE DISORDERS
#434Method for improving aqueous solubility of water-insoluble or slightly water-soluble drugs
#435POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS
#436Vaporized medicants and methods of use
#437Substrates for Enhancing Purity or Yield of Compounds Forming a Condensation Aerosol
#438Inhalers and Related Methods
#439Compositions and methods that promote hypoxia or the hypoxia response for treatment and prevention of mitochondrial dysfunction and oxidative stress disorders
#440Drug dose cartridge for an inhaler device
#441COMPOSITIONS FOR MANAGEMENT OF WOUNDS, SKIN DISEASES, DEHYDRATION, CHRONIC DISEASES, AND RESPIRATORY DISEASES
#442Methods for preventing and treating pneumocystis infections
#443METHODS OF INDUCING ANESTHESIA
#444Compositions and methods for enhancing sexual pleasure and performance
#445Method of improving sexual response and sensitivity
#446Inorganic nitrite to improve cardiopulmonary hemodynamics
#447Histone deacetylase inhibitors
#448Non-Invasive Applications for Bioactive Agents
#449Method of identifying a biologically-active composition from a biofilm
#450Device for delivery of smokable cannabis and manufacturing method for same
#451Method and device for vaporization and inhalation of isolated substances
#452BIOAVAILABLE AEROSOLIZED SUPPLEMENT FORMULATIONS
#453Methods, devices and systems for pulmonary delivery of active agents
#454Substrates for Drug Delivery Device and Methods of Preparing and Use
#455METHODS FOR TREATING INTRAPULMONARY INFECTIONS
#456HALOGENATED ETHER COMPOUNDS AND METHODS OF INDUCING ANESTHESIA
#457Vaporizer
#458Systems and methods for a cooled nitric oxide generator
#459EMOTIONAL MANIPULATION OF CONSUMERS OF DIGITAL CONTENT
#460USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#461Compositions and methods for treating and preventing lung injury
#462Self-foaming cleansing composition containing clobetasol propionate, and use thereof in the treatment of psoriasis
#463Electronic cigarette
#464TREATMENT OF ACUTE TRAUMATIC INJURY
#465Use of inhibitors of bruton's tyrosine kinase (Btk)
#466Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
#467Isolation of human lung progenitors derived from pluripotent stem cells
#468Food grade cannabis extracts and methods for their preparation
#469FUSOGENIC PROPERTIES OF SAPOSIN C AND RELATED PROTEINS AND PEPTIDES FOR APPLICATION TO TRANSMEMBRANE DRUG DELIVERY SYSTEMS
#470Chimeric compounds targeting proteins, compositions, methods, and uses thereof
#471Inhalers and related methods
#472Inhalers and related methods
#473Compositions for Vapor Phase Delivery of Active Compounds, Methods of Making and Using Same, and Kits Comprising Same
#474Treatment of mammalian physiological reaction of IgE antibodies present in said mammal upon contact with the corresponding antigen
#475TRANSGENIC EXPRESSION OF DNASEI IN VIVO DELIVERED BY AN ADENO-ASSOCIATED VIRUS VECTOR
#476Implantable drug delivery compositions and methods of use thereof
#477Vaporizing device
#478Targeted structure-specific particulate delivery systems
#479Therapeutic combination comprising a pulmonary surfactant and a steroid for the treatment of evolving BPD
#480Surfactant lipids, compositions thereof, and uses thereof
#481Ultrapure tetrahydrocannabinol-11-oic acids
#482Electronic cigarette
#483Vaporized medicants and methods of use
#484Nucleic acid aptamers to treat histone-induced disease states
#485NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#486Method for treating interstitial lung disease
#487INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES
#488INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES
#489Process for the preparation of a PDE4 inhibitor
#490Methods of inducing anesthesia
#491Vaporizer for vaporizing a constituent of a plant material
#492COMPOSITIONS, METHODS AND KITS FOR THE SAFE INHALED DELIVERY OF TARGETED OPIOIDS FOR THE TREATMENT OF PAIN AND ADDICTION
#493Vaporizing devices and methods for delivering a compound using the same
#494INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES
#495Dispersion anaesthetic device
#496Aerosol generator
#497Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia
#498Compositions and methods for treating respiratory injury or disease
#499Methods for treating intrapulmonary infections
#500Anti-fibrotic pyridinones
#501Amino-pyrimidine skeletal muscle modulators
#502Method and system for producing oxygen-rich vapor derived from herb-based plants
#503Method of treating an inflammatory disease using lactic acid bacteria-derived extracellular vesicles
#504Antiviral compositions for treating the flu
#505Use of inhibitors of Bruton's tyrosine kinase (Btk)
#506STEM CELL FACTOR INHIBITOR
#507Nicotine salt with meta-salicylic acid and applications therein
#508Unit aerosol doses for anticoagulation
#509Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease
#510Composition and methods for treatment of lung disorders characterized by cholesterol dysregulation
#511AROMATHERAPY ADHESIVE STRIP
#512Soothing pro-pheromonal composition for mammals
#513LOW DOSE NORIBOGAINE FOR TREATING NICOTINE ADDICTION AND PREVENTING RELAPSE OF NICOTINE USE
#514Method and system for drug delivery
#515Treatment of thrombocytopenia using orally administered interferon
#516Modulation of Amyloid Beta Toxicity and Processing By Xenon Gas
#517Soothing composition for animals, comprising at least one fatty acid and nepetalactone
#518Products for the delivery of therapeutic/diagnostic compounds to the heart
#519METHOD FOR ADMINISTERING TETRA-HYDROCANNABINOL IN TOBACCO
#520ANTI-IL-13/IL-17 BISPECIFIC ANTIBODIES AND USES THEREOF
#521COMPOSITION AND METHODS BASED ON NEUTRALIZING ANTIBODIES DELIVERED INTRANASALLY FOR ENHANCED THERAPEUTIC EFFICACY
#522Chimeric compounds targeting proteins, compositions, methods, and uses thereof
#523Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery
#524LIQUID COMPOSITION CONTAINING NICOTINE FROM NON-TOBACCO SOURCE FOR USE WITH ELECTRONIC VAPORIZING DEVICES
#525INGESTIBLE COMPOSITIONS SYSTEM AND METHOD
#526Administering the noble gas argon during cardiopulmonary resuscitation
#527INHALATION-TYPE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GOUT AND PREPARATION METHOD THEREOF
#528Dab2 inhibitors for the prevention and treatment of cystic fibrosis
#529Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor
#530Small molecule therapies for pulmonary hypertension
#531Mutant strains and methods of use
#532Aerosol forming device for use in inhalation therapy
#533Method of identifying a biologically-active composition from a biofilm
#534HIV-CURE
#535Oxygen-enabled composition
#536Capsaicinoid smoke
#537Methods for the treatment and prevention of asbestos-related diseases
#538Inhibition of pulmonary fibrosis with nutlin-3a and peptides
#539Conjugate with target-finding ligand and use thereof
#540Rosemary in a tobacco blend
#541Polyol-based osmotic polydixylitol polymer gene transporter and use thereof
#542Method of preventing or treating influenza with oxidative reductive potential water solution
#543Positively charged co-polymers for use as antimicrobial agents
#544Dry eye treatments
#545Non-burning type flavor inhaler and control method
#546Method and compositions for solubilizing non-polar constituents
#547Methods of identifying and treating premature infants at risk for BPD
#548Cannabis Pellets
#549Continuous gas generator
#550NOBLE GAS TREATMENT OF ALZHEIMER'S DISEASE AND TAUPATHIES
#551Use of ultrarapid acting insulin
#552XENON ASSOCIATED WITH AN NMDA RECEPTOR ANTAGONIST FOR CONTROLLING TUMOR PROLIFERATION IN THE CENTRAL NERVOUS SYSTEM
#553HEADACHE PRE-EMPTION BY DIHYDROERGOTAMINE TREATMENT DURING HEADACHE PRECURSOR EVENTS
#554Use of miR-199a-5p, targets and/or inhibitors thereof for the diagnosis, prognosis and treatment of fibroproliferative disorders
#555Wax melt compositions having increased thermal stability
#556METHOD AND APPARATUS FOR ADMINISTERING NITRIC OXIDE WITH SUPPLEMENTAL DRUGS
#557Method of reducing oral biofilm
#558Polypeptides, antibody variable domains and antagonists
#559MEASUREMENT OF BODY FLUID VOLUMES
#560Fibrosis-causing agent
#561METHOD AND APPARATUS FOR SCAVENGING PLASMA FREE HEMOGLOBIN
#562Methods, devices and systems for pulmonary delivery of active agents
#563CANNABINOID FORMULATION FOR THE SEDATION AND/OR ANAESTHETIZING OF A HUMAN OR ANIMAL
#564THERAPEUTIC COMPOSITIONS COMPRISING HERBAL EXTRACTS AND ESSENTIAL OILS FOR SMOKING AND VAPORIZATION
#565Therapeutic/ preventive agent containing coumarin derivative as active ingredient
#566HVAC fluid dispersant system
#567Flow regulating inhaler device
#568TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS
#569WATER-BASED VAPORIZABLE LIQUIDS, METHODS AND SYSTEMS FOR VAPORIZING SAME
#570Powder for delivery to the oral cavity
#571Method and Medicament for Pain Management
#572Medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity
#573Flow regulating inhaler device
#574ACTH prophylactic treatment of renal disorders
#575Use of retinoic acid and analogs thereof to treat central neural apneas
#576Drug dose cartridge for an inhaler device
#577CHEMICALLY MODIFIED SMALL MOLECULES
#578WINTERIZED CRUDE CANNABIS EXTRACTS AND METHODS OF PREPARATION AND USE
#579COMBINATION OF XENON AND AN ANTIOXIDANT TO CONTROL A PARKINSON'S DISEASE-TYPE NEURODEGENERATIVE DISEASE
#580Pre-vaporization formulation for controlling acidity in an e-vaping device
#581LIQUID FORMULATION COMPRISING NICOTINE FOR AEROSOL ADMINISTRATION
#582Method and system for reducing the likelihood of a spirochetes infection in a human being
#583Ultrapure tetrahydrocannabinol-11-oic acids
#584Ultrapure tetrahydrocannabinol-11-oic acids
#585Ultrapure tetrahydrocannabinol-11-oic acids
#586INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES
#587LIGHT INHIBITORS FOR ASTHMA, LUNG AND AIRWAY INFLAMMATION, RESPIRATORY, INTERSTITIAL, PULMONARY AND FIBROTIC DISEASE TREATMENT
#588Method of identifying a biologically-active composition from a biofilm
#589Method of identifying a biologically-active composition from a biofilm
#590Methods for improving drug efficacy
#591Heating unit for use in a drug delivery device
#592Use of anti-bacterial agents for the treatment of epithelial-related conditions
#593Treatment of thrombocytopenia using orally administered interferon
#594Use of inhibitors of Bruton'S tyrosine kinase (Btk)
#595Suppression of allergic lung inflammation and hyperreactivity
#596Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance
#597Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
#598HOMEOPATHIC PROCEDURE FOR THE NEUTRALIZATION OF DAMAGE FROM CIGARETTE SMOKE AND NEUTRALIZED CIGARETTE OBTAINED THEREFROM
#599Methods and materials for reducing the severity of viral infections
#600Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy